Inventor · disambiguated record
Linda Snyder
Also filed as: SNYDER LINDA · SNYDER LINDA A · SNYDER LINDA ANNE · SNYDER LINDA L
34 granted patents·21 pending applications·363 citations·filing 1996–2025
97Inventor score
Files withJANSSEN PHARMACEUTICA NV20IMMUNEXT INC10CENTOCOR INC7GILES-KOMAR JILL3JANSSEN BIOTECH INC3
Top patents by PatentIndex Score
55 records- 0197US7550142B2Anti-integrin antibodies, compositions, methods and usesCENTOCOR INC·Filed 2006·Granted Jun 23, 2009·71 cites·14 claims
- 0297US7163681B2Anti-integrin antibodies, compositions, methods and usesCENTOCOR INC·Filed 2003·Granted Jan 16, 2007·132 cites·20 claims
- 0396US8071729B2Anti-integrin antibodies, compositions, methods and usesGILES-KOMAR JILL·Filed 2007·Granted Dec 6, 2011·51 cites·21 claims
- 0495US12188938B2Anti-VISTA antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jan 7, 2025·4 cites·18 claims
- 0595US11987630B2Anti-vista antibodies and fragments, uses thereof, and methods of identifying sameJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 21, 2024·4 cites·2 claims
- 0693US12139532B2Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted Nov 12, 2024·4 cites·14 claims
- 0793US11242392B2Anti-vista antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Feb 8, 2022·4 cites·32 claims
- 0893US11009509B2Anti-VISTA antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 18, 2021·7 cites·26 claims
- 0992US11603403B2Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted Mar 14, 2023·4 cites·11 claims
- 1092US11014987B2Anti-vista antibodies and fragments, uses thereof, and methods of identifying sameJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 25, 2021·9 cites·16 claims
- 1192US10899836B2Method of identifying anti-VISTA antibodiesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·6 cites·5 claims
- 1291US11649283B2Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted May 16, 2023·4 cites·24 claims
- 1390US11603402B2Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted Mar 14, 2023·4 cites·9 claims
- 1490US11207311B2Method of treating prostate cancerJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Dec 28, 2021·6 cites·23 claims
- 1590US2025263485A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2024·Application pending·0 cites
- 1687US11525000B2Anti-human VISTA antibodies and use thereofIMMUNEXT INC·Filed 2017·Granted Dec 13, 2022·4 cites·20 claims
- 1786US11986470B2Methods of treating prostate cancerJANSSEN PHARMACEUTICA NV·Filed 2023·Granted May 21, 2024·0 cites·22 claims
- 1886US10273301B2Anti-vista antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 30, 2019·7 cites·44 claims
- 1984US2024018238A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2023·Application pending·0 cites
- 2084US2025354994A1Anti-vista antibodies and fragmentsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2184US2025346666A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2025·Application pending·0 cites
- 2283US11992486B2Methods of treating prostate cancerJANSSEN PHARMACEUTICA NV·Filed 2022·Granted May 28, 2024·0 cites·12 claims
- 2383US11986468B2Methods of treating prostate cancerJANSSEN PHARMACEUTICA NV·Filed 2022·Granted May 21, 2024·0 cites·22 claims
- 2483US11986469B2Methods of treating prostate cancerJANSSEN PHARMACEUTICA NV·Filed 2022·Granted May 21, 2024·0 cites·22 claims
- 2583US8071333B2Anti-integrin antibodies, compositions, methods and usesGILES-KOMAR JILL·Filed 2009·Granted Dec 6, 2011·4 cites·3 claims
- 2683US2024067719A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2022·Application pending·0 cites
- 2782US2024141037A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2023·Application pending·0 cites
- 2879US12383543B2Methods of treating prostate cancerJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 12, 2025·0 cites·19 claims
- 2979US10730950B2GITR antibodies, methods, and usesJANSSEN BIOTECH INC·Filed 2017·Granted Aug 4, 2020·2 cites·12 claims
- 3077US2024398837A1Combination Therapy For Prostate CancerJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 3176US8663980B2Vectors, host cells, and methods of production and usesCARTON JILL·Filed 2008·Granted Mar 4, 2014·2 cites·11 claims
- 3276US2024245710A1Combination Therapy For Prostate CancerJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 3373US7666993B2Cynomolgus prostate specific antigenCENTOCOR INC·Filed 2008·Granted Feb 23, 2010·1 cites·4 claims
- 3472US7288390B2Anti-dual integrin antibodies, compositions, methods and usesCENTOCOR INC·Filed 2001·Granted Oct 30, 2007·5 cites·14 claims
- 3572US5851804AChimeric kanamycin resistance geneAPOLLON INC·Filed 1996·Granted Dec 22, 1998·26 cites·29 claims
- 3670US7342107B2Cynomolgus prostate specific antigenCENTOCOR INC·Filed 2005·Granted Mar 11, 2008·1 cites·8 claims
- 3769US2022175801A1Combination Therapy For Prostate CancerJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 3868US12441801B2Anti-VISTA antibodies and fragments, uses thereof, and methods of identifying sameJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 14, 2025·0 cites·12 claims
- 3966US8980626B2Vectors, host cells, and methods of production and usesJANSSEN BIOTECH INC·Filed 2014·Granted Mar 17, 2015·0 cites·18 claims
- 4066US8138315B2Anti-alpha V immunoliposome compositions, methods and usesGOLDSTEIN JOSHUA·Filed 2011·Granted Mar 20, 2012·1 cites·8 claims
- 4163US2018296574A1Combination Therapy for Prostate CancerJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 4262US2018028521A1Methods of Treating Prostate CancerJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 4360US9206248B2Vectors, host cells, and methods of production and usesJANSSEN BIOTECH INC·Filed 2015·Granted Dec 8, 2015·0 cites·13 claims
- 4458US7736650B2Anti-IL-12 antibody based vectors, host cells, and methods of production and usesCENTOCOR INC·Filed 2005·Granted Jun 15, 2010·0 cites·4 claims
- 4557US2003235891A1Method for generating monoclonal antibodiesFiled 2003·Application pending·0 cites
- 4656US2012058128A1Anti- integrin antibodies, compositions, methods and usesGILES-KOMAR JILL·Filed 2011·Application pending·0 cites
- 4756US2009175784A1Anti-Alpha V Immunoliposome Composition, Methods, and UsesGOLDSTEIN JOSHUA·Filed 2008·Application pending·0 cites
- 4852US8361474B2Anti-IL-12 antibody based vectors, host cells, and methods of production and usesCENTOCOR INC·Filed 2010·Granted Jan 29, 2013·0 cites·4 claims
- 4952US2006246061A1Method for generating monoclonal antibodiesMBOW M L·Filed 2006·Application pending·0 cites
- 5050US2016015700A14-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide for the treatment of hodgkin's lymphomaDE BOER CARLA·Filed 2014·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Linda Snyder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →